Lexicon Pharmaceuticals, Inc. (LXRX) stock
LXRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3087% above fair value
$1.78+0.03 (+1.71%)
Close on Nov 17, 2026Market cap $792.02MP/E –Yield –
Lexicon Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Lexicon Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was -147.4%. For fiscal 2025 it was -101.1%, against -644.8% the year before. The highest annual figure on record is 40.4% in fiscal 2019.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -101.1% | +543.7 |
| FY2024 | Dec 31, 2024 | -644.8% | +14066.1 |
| FY2023 | Dec 31, 2023 | -14710.9% | +58630.1 |
| FY2022 | Dec 31, 2022 | -73341.0% | −43892.0 |
| FY2021 | Dec 31, 2021 | -29449.0% | −29204.9 |
| FY2020 | Dec 31, 2020 | -244.1% | −284.5 |
| FY2019 | Dec 31, 2019 | 40.4% | +231.1 |
| FY2018 | Dec 31, 2018 | -190.7% | −56.6 |
| FY2017 | Dec 31, 2017 | -134.1% | +31.7 |
| FY2016 | Dec 31, 2016 | -165.8% | −162.2 |
| FY2015 | Dec 31, 2015 | -3.6% | +435.2 |
| FY2014 | Dec 31, 2014 | -438.8% | +4247.3 |
| FY2013 | Dec 31, 2013 | -4686.1% | +5434.2 |
| FY2012 | Dec 31, 2012 | -10120.4% | −3835.1 |
| FY2011 | Dec 31, 2011 | -6285.3% | −4211.6 |
| FY2010 | Dec 31, 2010 | -2073.7% | −1300.0 |
| FY2009 | Dec 31, 2009 | -773.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -4591.8% | −4603.0 |
| Q1 FY2026 | Mar 31, 2026 | -4.9% | +1999.4 |
| Q4 FY2025 | Dec 31, 2025 | -282.7% | −155.6 |
| Q3 FY2025 | Sep 30, 2025 | -90.0% | +3613.4 |
| Q2 FY2025 | Jun 30, 2025 | 11.3% | +3255.3 |
| Q1 FY2025 | Mar 31, 2025 | -2004.4% | +2278.6 |
| Q4 FY2024 | Dec 31, 2024 | -127.2% | +6960.6 |
| Q3 FY2024 | Sep 30, 2024 | -3703.5% | +27484.8 |
| Q2 FY2024 | Jun 30, 2024 | -3244.0% | +10921.3 |
| Q1 FY2024 | Mar 31, 2024 | -4282.9% | +128775.4 |
| Q4 FY2023 | Dec 31, 2023 | -7087.7% | +101819.4 |
| Q3 FY2023 | Sep 30, 2023 | -31188.3% | +28778.4 |
| Q2 FY2023 | Jun 30, 2023 | -14165.3% | +56083.3 |
| Q1 FY2023 | Mar 31, 2023 | -133058.3% | +49877.4 |
| Q4 FY2022 | Dec 31, 2022 | -108907.1% | −8376.7 |
| Q3 FY2022 | Sep 30, 2022 | -59966.7% | −52245.7 |
| Q2 FY2022 | Jun 30, 2022 | -70248.6% | +7373.7 |
| Q4 FY2021 | Dec 31, 2021 | -182935.7% | −180174.4 |
| Q3 FY2021 | Sep 30, 2021 | -100530.4% | −101775.6 |
| Q2 FY2021 | Jun 30, 2021 | -7720.9% | −6967.1 |
| Q1 FY2021 | Mar 31, 2021 | -77622.2% | −76789.5 |
| Q4 FY2020 | Dec 31, 2020 | -2761.3% | −2175.3 |
| Q3 FY2020 | Sep 30, 2020 | 1245.1% | +1168.4 |
| Q2 FY2020 | Jun 30, 2020 | -753.8% | −516.1 |
| Q1 FY2020 | Mar 31, 2020 | -832.7% | −596.2 |
| Q4 FY2019 | Dec 31, 2019 | -586.0% | −487.7 |
| Q3 FY2019 | Sep 30, 2019 | 76.8% | +470.1 |
| Q2 FY2019 | Jun 30, 2019 | -237.7% | +12.7 |
| Q1 FY2019 | Mar 31, 2019 | -236.5% | −71.7 |
| Q4 FY2018 | Dec 31, 2018 | -98.3% | −20.0 |
| Q3 FY2018 | Sep 30, 2018 | -393.3% | −285.6 |
| Q2 FY2018 | Jun 30, 2018 | -250.4% | +36.3 |
| Q1 FY2018 | Mar 31, 2018 | -164.8% | +12.9 |
| Q4 FY2017 | Dec 31, 2017 | -78.3% | +62.4 |
| Q3 FY2017 | Sep 30, 2017 | -107.7% | +22.2 |
| Q2 FY2017 | Jun 30, 2017 | -286.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -177.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -140.7% | – |
| Q3 FY2016 | Sep 30, 2016 | -129.9% | – |
See a number that looks wrong?